Dow agrees to sell its 50% interest in DowAksa Advanced Composites Holdings BV (DowAksa) to its 50/50 joint venture partner Aksa Akrilik Kimya Sanayii A.Ş. Proceeds will be used to support Dow's balanced capital allocation approach MIDLAND, Mich.

Transaction enables the Company to further focus on core, high-value downstream markets Proceeds will be used to support Dow's balanced capital allocation approach MIDLAND, Mich. , May 1, 2025 /PRNewswire/ -- Dow (NYSE: DOW) announced today the completion of the sale of Telone™, a soil fumigation product to TriCal Soil Solutions, Inc., a leading distributor and applicator of soil fumigation products.

Dow sold an initial 40% equity stake in Diamond Infrastructure Solutions, a dedicated infrastructure company with assets across the U.S. Gulf Coast, to a fund managed by Macquarie Asset Management Macquarie Asset Management has an option to increase its equity stake to 49% within six months of closing Dow received initial cash proceeds of approximately $2.4 billion, with potential to receive up to approximately $3.0 billion in total if the option is exercised Proceeds will be used to support Dow's balanced capital allocation approach  MIDLAND, Mich. , May 1, 2025 /PRNewswire/ -- Dow (NYSE: DOW) today announced the completion of the sale of a 40% equity stake in Diamond Infrastructure Solutions, a dedicated infrastructure company with select U.S. Gulf Coast infrastructure assets, to a fund managed by Macquarie Asset Management, a leading global infrastructure and energy asset manager.

Launches Action Plan to Further Reduce Spending, Right-Size Capacity, and Deliver $6 Billion in Cash Support MIDLAND, Mich. , April 24, 2025 /PRNewswire/ -- Dow (NYSE: DOW): 1Q25 FINANCIAL HIGHLIGHTS Net sales were $10.4 billion, down 3% year-over-year, reflecting declines in all operating segments.

Declares quarterly dividend of 70 cents per share Richard K. Davis re-elected independent lead director MIDLAND, Mich.

WASHINGTON, April 10, 2025 (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), will participate in a scientific discussion on the management and treatment of babesiosis during the April 15–21 Healing Lyme Summit. Babesiosis is a rapidly emerging tick-borne disease often found as a coinfection with Lyme disease.

Q1 2025 U.S. common dividend increases were $19.5 billion, up 37.0% from $14.2 billion in Q4 2024 and down 14.1% from $22.7 billion in Q1 2024. Q1 2025 U.S. common dividend decreases were $4.2 billion, up 68.0% from $2.5 billion in Q4 2024, and down 37.7% from $6.7 billion in Q1 2024.

NEW YORK--(BUSINESS WIRE)--Dow Jones today announced the launch of Dow Jones Risk Journal, a premium news solution from its risk and compliance business providing personalized and actionable insights to enable leaders to manage risk and make informed business decisions. Dow Jones Risk Journal provides comprehensive news and intelligence from a dedicated newsroom of expert journalists who specialize in covering risk and compliance issues, as well as in-depth and nuanced analysis of regulations a.

Project supported by U.S. DOE's Advanced Reactor Demonstration Program Represents a key milestone toward bringing advanced nuclear energy to fruition in the U.S.  MIDLAND, Mich. and ROCKVILLE, Md.